Home Cart Sign in  
Chemical Structure| 1197160-78-3 Chemical Structure| 1197160-78-3

Structure of Gedatolisib
CAS No.: 1197160-78-3

Chemical Structure| 1197160-78-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

PKI-587 is a highly potent dual PI3K/mTOR kinase inhibitor with IC50 of 0.4 nM, 5.4 nM and 1.6 nM for PI3Kα, PI3Kγ and mTOR, respectively.

Synonyms: PKI-587; PF-05212384; PF5212384

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Gedatolisib

CAS No. :1197160-78-3
Formula : C32H41N9O4
M.W : 615.73
SMILES Code : O=C(NC1=CC=C(C2=NC(N3CCOCC3)=NC(N4CCOCC4)=N2)C=C1)NC5=CC=C(C(N6CCC(N(C)C)CC6)=O)C=C5
Synonyms :
PKI-587; PF-05212384; PF5212384
MDL No. :MFCD16875679
InChI Key :DWZAEMINVBZMHQ-UHFFFAOYSA-N
Pubchem ID :44516953

Safety of Gedatolisib

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Gedatolisib

PI3K-AKT

Isoform Comparison

Biological Activity

Target
  • p110γ

    PI3Kγ, IC50:5.4 nM

  • p110α

    PI3Kα, IC50:0.4 nM

  • mTOR

    mTOR, IC50:1.6 nM

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02438761 Therapy-related Acute Myeloid ... More >>Leukemia and Myelodysplastic Syndrome|Acute Myeloid Leukemia, in Relapse|de Novo Acute Myeloid Leukemia at Diagnostic Less << PHASE2 TERMINATED 2018-04-23 H?pital Saint-Louis, Paris, Il... More >>e De France, 75475, France|H?pital Cochin, Paris, Ile De France, 75679, France|Institut Curie - H?pital René Huguenin, Saint-Cloud, Ile De France, 92210, France|CHU de Toulouse, Toulouse, Midi-Pyrénées, 31059, France|Institut Paoli Calmette, Marseille, Paca, 13009, France Less <<
NCT02142920 Healthy PHASE1 COMPLETED 2025-08-14 Pfizer Investigational Site, R... More >>uddington Fields, Nottingham, NG11 6JS, United Kingdom Less <<
NCT05134922 Breast Neoplasm Malignant Fema... More >>le Less << AVAILABLE - University of Alabama at Birmi... More >>ngham, Birmingham, Alabama, 35233, United States|University of Michigan, Ann Arbor, Michigan, 48109, United States|Ohio State University Comprehensive Cancer Center, Columbus, Ohio, 43210, United States|The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States|Seattle Cancer Care Alliance, Seattle, Washington, 98109, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.62mL

0.32mL

0.16mL

8.12mL

1.62mL

0.81mL

16.24mL

3.25mL

1.62mL

References

 

Historical Records

Categories